Five months after drug makers began openly blaming pharmacy benefit managers for rising prices, these crucial middlemen in the arcane and complicated health care system are starting to fight back.

On Monday, the trade group representing pharmacy benefits managers, which negotiate prices on behalf of health plans and create lists of drug that receive preferred coverage, circulated a memo to its members outlining a six-point plan designed to push back against mounting criticism of their business.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • As a pharmvet I can say this is the most unholy alliance since John Looney ran the Rock Island Gang during the Depression.

    -Pharmaceutical Companies
    -In a few cases doctors

    To paraphrase Paul Newman, who played Looney in “The Road to Perdition”. none of them will see heaven.

  • This is outstanding Ed, especially the link to the actual memo!

    Now why is it that there is no similar memo from the PhRMA to its members? At least I am not ware of any. Can you find out please?

    Also, would it be possible for you to interview Express Scripts’ Stephen Miller based on this memo, since he has been very vocal last year?

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy